SEC Filings
MBX Biosciences' Administrative Costs Reach $34.3 Million From $4.7 Million As Stock-Award Expense Climbs
Former-CEO award changes added $20.8 million in expense, while MBX expects its cash and investments to fund operations into 2029.
MBX Biosciences (MBX) news from Bullished: SEC filings, earnings, insider trades and deals, explained in plain English with links to the source documents.
SEC Filings
Former-CEO award changes added $20.8 million in expense, while MBX expects its cash and investments to fund operations into 2029.
SEC Filings
The new Class I director gets an option on 18,200 shares and serves until the 2028 annual meeting, the 8-K says.